BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36267311)

  • 21. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment.
    Wu B; Tao L; Yang D; Li W; Xu H; He Q
    Biomed Res Int; 2020; 2020():2719739. PubMed ID: 32908876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Biomarkers Associated with the Prognoses of Colorectal Cancer Patients.
    Fang Y; Zhan X
    Digestion; 2023; 104(2):148-162. PubMed ID: 36577392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
    Gao X; Yang J
    DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated analysis of RNA-binding proteins in human colorectal cancer.
    Fan X; Liu L; Shi Y; Guo F; Wang H; Zhao X; Zhong D; Li G
    World J Surg Oncol; 2020 Aug; 18(1):222. PubMed ID: 32828126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
    Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
    Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Sharma A; Yadav D; Rao P; Sinha S; Goswami D; Rawal RM; Shrivastava N
    Comput Biol Med; 2022 Jul; 146():105688. PubMed ID: 35680454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 32. Construction and evaluation of a prognostic risk model of tumor metastasis-related genes in patients with non-small cell lung cancer.
    Ding H; Shi L; Chen Z; Lu Y; Tian Z; Xiao H; Deng X; Chen P; Zhang Y
    BMC Med Genomics; 2022 Sep; 15(1):187. PubMed ID: 36056349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integration of machine learning for developing a prognostic signature related to programmed cell death in colorectal cancer.
    Xu QT; Qiang JK; Huang ZY; Jiang WJ; Cui XM; Hu RH; Wang T; Yi XL; Li JY; Yu Z; Zhang S; Du T; Liu J; Jiang XH
    Environ Toxicol; 2024 May; 39(5):2908-2926. PubMed ID: 38299230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prognostic fibroblast-related risk signature in colorectal cancer.
    Xu H; Pan Y
    Aging (Albany NY); 2021 Nov; 13(21):24251-24270. PubMed ID: 34735373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
    Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
    World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel Immune-Related prognostic model for patients with colorectal cancer based on 3 subtypes.
    Yang X; Wei Q
    Immunobiology; 2023 Mar; 228(2):152352. PubMed ID: 36827833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
    Zhang H; Dong S; Feng J
    J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Machine learning and network-based models to identify genetic risk factors to the progression and survival of colorectal cancer.
    Hossain MJ; Chowdhury UN; Islam MB; Uddin S; Ahmed MB; Quinn JMW; Moni MA
    Comput Biol Med; 2021 Aug; 135():104539. PubMed ID: 34153790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a 12-gene prognostic model for colorectal cancer based on heat shock protein-related genes.
    Tong Q; Zhou J
    Int J Hyperthermia; 2024; 41(1):2290913. PubMed ID: 38191150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Novel Prognostic Biomarkers for Colorectal Cancer by Bioinformatics Analysis.
    Niu C; Li X; Lei Luo X; Wan H; Jin W; Zhang Z; Zhang W; Li B
    Turk J Gastroenterol; 2024 Jan; 35(1):61-72. PubMed ID: 38454278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.